Journey Medical (DERM) Receivables (2020 - 2025)
Historic Receivables for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to $18.0 million.
- Journey Medical's Receivables rose 6852.22% to $18.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.0 million, marking a year-over-year increase of 6852.22%. This contributed to the annual value of $10.2 million for FY2024, which is 3278.81% down from last year.
- Journey Medical's Receivables amounted to $18.0 million in Q3 2025, which was up 6852.22% from $15.6 million recorded in Q2 2025.
- In the past 5 years, Journey Medical's Receivables ranged from a high of $31.7 million in Q3 2021 and a low of $8.0 million during Q3 2023
- For the 5-year period, Journey Medical's Receivables averaged around $19.5 million, with its median value being $18.0 million (2025).
- As far as peak fluctuations go, Journey Medical's Receivables tumbled by 7200.08% in 2023, and later soared by 8394.73% in 2025.
- Journey Medical's Receivables (Quarter) stood at $23.1 million in 2021, then increased by 22.05% to $28.2 million in 2022, then tumbled by 46.04% to $15.2 million in 2023, then plummeted by 32.79% to $10.2 million in 2024, then skyrocketed by 75.77% to $18.0 million in 2025.
- Its last three reported values are $18.0 million in Q3 2025, $15.6 million for Q2 2025, and $18.0 million during Q1 2025.